MediPix Ltd

MediPix Ltd
Name	MediPix Ltd
Type	Private
Industry	Medical imaging
Founded	2009
Founders	Jonathan F. Smith; Maria L. Ortega
Headquarters	Cambridge, United Kingdom
Products	Photon-counting detectors; digital radiography systems; software
Num employees	120 (2024)

MediPix Ltd is a British company specializing in photon-counting X-ray detector technology and advanced digital radiography systems. It develops hardware and software intended for diagnostic imaging, industrial inspection, and preclinical research. The company has been active in translational research and commercialization efforts within the biomedical technology sector.

History

MediPix Ltd was founded in 2009 by engineers and physicists motivated by developments in semiconductor detector research appearing alongside projects at University of Cambridge, Imperial College London, and CERN. Early seed funding came from regional investors associated with the Cambridge Science Park and business accelerator programs linked to Tech Nation and UK Research and Innovation. The company grew through participation in collaborative grants with Medical Research Council units and technology transfer offices at Addenbrooke's Hospital. Key milestones include prototype demonstrations at conferences such as European Congress of Radiology and product launches timed with trade shows like RSNA.

Products and Technology

MediPix Ltd produces photon-counting detector modules based on semiconductor materials and custom ASICs influenced by developments at CERN and academic groups at University of Oxford and University College London. Its product line includes compact digital radiography systems, flat-panel detectors, and software suites for spectral imaging and image reconstruction that integrate algorithms derived from research at Wellcome Trust Sanger Institute and collaborations with teams from the Francis Crick Institute. The hardware architecture references standards used in DICOM workflows and employs interfaces compatible with systems from manufacturers such as Siemens Healthineers, Philips, and GE Healthcare. Patents and design work cite techniques from sensor research at Massachusetts Institute of Technology and Stanford University.

Clinical Applications and Research

Clinical applications promoted by the company include low-dose chest radiography, mammography adjuncts, and musculoskeletal imaging evaluated in trials at institutions like Addenbrooke's Hospital, Guy's and St Thomas' NHS Foundation Trust, and research centers affiliated with King's College London. Preclinical and translational studies have been conducted in partnership with laboratories at University of Edinburgh and University of Manchester. The company has contributed hardware and software to multi-center studies overseen by consortia associated with National Institute for Health and Care Research and collaborates with investigator groups from Harvard Medical School and Johns Hopkins University on spectral imaging applications and quantitative biomarkers.

Regulatory Approvals and Compliance

MediPix Ltd pursued conformity routes for medical devices in jurisdictions such as the United Kingdom and the European Union. The company engaged with regulatory frameworks overseen by agencies including the Medicines and Healthcare products Regulatory Agency and the European Medicines Agency for compliance with device directives and in vitro diagnostic regulations. For markets outside Europe, enrollment in certification processes involved standards recognized by agencies like the U.S. Food and Drug Administration and regional bodies in Japan and Canada. Quality management systems were implemented following ISO standards used by peers such as Roche and Siemens Healthineers.

Corporate Structure and Funding

The corporate structure includes a board with academics and industry executives drawn from institutions such as University of Cambridge and firms like Oxford Instruments. Funding rounds combined venture capital from specialized medical technology funds, grants from Horizon 2020 programs, and strategic investments from corporate partners including multinational medical device companies and regional investment bodies linked to British Business Bank. Leadership transitions included appointments of executives with prior roles at Philips and GE Healthcare.

Partnerships and Collaborations

MediPix Ltd established collaborations with academic partners such as Imperial College London, University College London, and King's College London, and industrial partners including Siemens Healthineers, Philips, and smaller system integrators. Research consortia included members from Wellcome Trust, European Molecular Biology Laboratory, and technology clusters around Cambridge Biomedical Campus. The company presented joint work at conferences including Radiological Society of North America and European Society of Radiology, and engaged in collaborative projects funded by Innovate UK and multinational grant programs.

Reception and Impact

The company attracted attention in trade journals and technology sections of outlets covering medical devices, with commentary from analysts familiar with companies like Canon Medical Systems and Toshiba Medical Systems. Clinical researchers acknowledged potential benefits of photon-counting technology for spectral contrast and dose reduction in articles co-authored by investigators at Addenbrooke's Hospital and Guy's Hospital. Competitors and collaborators in the market include established imaging firms such as GE Healthcare and emerging startups spun out of CERN and university labs. Ongoing debates in the field relate to cost-effectiveness assessments performed by healthcare bodies such as NICE and implementation strategies within hospital systems.

Category:Medical imaging companies Category:Companies based in Cambridge